Use of CTLA4Ig in combination with conventional immunosuppressive agents to prolong allograft survival
Hale DA, Gottschalk R, Maki T, Monaco AP (1997) Use of CTLA4Ig in combination with conventional immunosuppressive agents to prolong allograft survival. Transplantation 64: 897-900
Effect of anti-CD4 monoclonal antibody combined with human CTLA4Ig on the survival of hamster liver and heart xenografts in Lewis rats
Yin DP, Sankary HN, Chong AS, Blinder L, Ma LL, Williams JW (1997) Effect of anti-CD4 monoclonal antibody combined with human CTLA4Ig on the survival of hamster liver and heart xenografts in Lewis rats. Transplantation 64: 317-321
Efficient generation of recombinant adenovirus using adenovirus DNA - Terminal protein complex and a cosmid bearing full-length virus genome
Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I (1996) Efficient generation of recombinant adenovirus using adenovirus DNA - terminal protein complex and a cosmid bearing full-length virus genome. Proc Natl Acad Sci USA 93: 1320-1324
Immunosuppression in vivo by a soluble form of the CTLA-4 T-cell activation molecule
Linsley PS, Wallace PM, Johnson J, Gibson MG, Greece JL, Ledbetter JA, Singh C, Tepper MA (1992) Immunosuppression in vivo by a soluble form of the CTLA-4 T-cell activation molecule. Science 257: 792-795
Evidence that the adenoviral vector containing the CTLA4-Ig gene improves transgene expression and graft survival
Namii Y, Hayashi S, Yokoyama I, Kobayashi T, Yasutomi M, Nagasaka T, Uchida K, Hamada H, Takagi H (1997) Evidence that the adenoviral vector containing the CTLA4-Ig gene improves transgene expression and graft survival. Transplant Proc 29: 1738-1739
Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig
Olthoff KM, Judge TA, Gelman AE, Shen XD, Hancock WW, Turka LA, Shaked A (1998) Adenovirus-mediated gene transfer into cold-preserved liver allografts: survival pattern and unresponsiveness following transduction with CTLA4Ig. Nat Med 4: 194-200
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91: 4407-4411